Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T VandenDriessche

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Blood|July 27, 2000
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factorM Jacquemin, R Lavend'homme, A Benhida, et al.
Nature Communications|February 1, 2019
Next-generation muscle-directed gene therapy by in silico vector designS Sarcar, W Tulalamba, M Y Rincon, et al.
Nature Medicine|May 1, 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsP Carmeliet, L Moons, A Luttun, et al.
Current Gene Therapy|November 9, 2010
Relevance of an academic GMP Pan-European vector infra-structure (PEVI)O Cohen-Haguenauer, N Creff, P Cruz, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Blood|July 27, 2000
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factorM Jacquemin, R Lavend'homme, A Benhida, et al.
Nature Communications|February 1, 2019
Next-generation muscle-directed gene therapy by in silico vector designS Sarcar, W Tulalamba, M Y Rincon, et al.
Nature Medicine|May 1, 2001
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsP Carmeliet, L Moons, A Luttun, et al.
Current Gene Therapy|November 9, 2010
Relevance of an academic GMP Pan-European vector infra-structure (PEVI)O Cohen-Haguenauer, N Creff, P Cruz, et al.
Pageof 4